» Articles » PMID: 18815938

Management of Cocaine-induced Cardiac Arrhythmias Due to Cardiac Ion Channel Dysfunction

Overview
Publisher Informa Healthcare
Specialty Toxicology
Date 2008 Sep 26
PMID 18815938
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine use is common in many areas of the world, particularly the United States and Western Europe. Toxicity following the use of cocaine is associated with a wide range of clinical features. In this review, we will focus on the cocaine-associated cardiac arrhythmias and, in particular, some of the controversies in their etiology and management. Cocaine can produce arrhythmias either through the production of myocardial ischemia or as a direct result of ion channel alterations. Excessive catecholamines, combined with sodium and potassium channel blockades, give rise to a wide variety of supra-ventricular and ventricular rhythms. The animal and human evidence for ion channel dysfunction is reviewed, and the effects of catecholamines are followed from the cardiac action potential to the development of arrhythmias. Finally, theoretical constructs are combined with existing evidence to develop a rational treatment strategy for patients with cocaine-induced cardiac arrhythmias. In particular, we review the evidence concerning the controversies relating to the use of lidocaine in comparison with sodium bicarbonate, in terms of QRS prolongation secondary to sodium channel blockade.

Citing Articles

Interaction of alcohol and other potentially cardiotoxic substances with the cardiovascular system.

Maisch B Herz. 2024; 49(6):405-408.

PMID: 39601836 PMC: 11602791. DOI: 10.1007/s00059-024-05281-y.


The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

J Addict Med. 2024; 18(1S Suppl 1):1-56.

PMID: 38669101 PMC: 11105801. DOI: 10.1097/ADM.0000000000001299.


Accelerated Idioventricular Rhythm Following Intraoral Local Anesthetic Injection During General Anesthesia.

Sato K, Miyamae Y, Kan M, Sato S, Yaegashi M, Sakanoue W Anesth Prog. 2021; 68(4):230-234.

PMID: 34911065 PMC: 8674851. DOI: 10.2344/anpr-68-03-09.


Antidotes for childhood toxidromes.

Hon K, Hui W, Leung A Drugs Context. 2021; 10.

PMID: 34122588 PMC: 8177957. DOI: 10.7573/dic.2020-11-4.


Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications.

Wei Y, Shah R Pharmaceuticals (Basel). 2020; 13(7).

PMID: 32708495 PMC: 7407364. DOI: 10.3390/ph13070155.